Bio Protocol vs Shentu — how do they compare? Bio Protocol trades at Rp514.95 (market cap Rp1,15T, Rp260,42M 24h volume), while Shentu trades at Rp1,837 (market cap Rp296,63M, Rp12,7M 24h volume). The key difference: Bio Protocol is far larger — about 3876.9× Shentu's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Shentu's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Shentu for 43 Days on average.
| BIO | CTK | |
|---|---|---|
Market Cap | Rp1,15T | Rp296,63M |
Volume (24h) | Rp260,42M | Rp12,7M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 161,4M CTK |
Typical Hold Time | 16 Days | 43 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Shentu (CTK) is trading at Rp1,837 with a market cap of Rp295.46 million, showing bearish technical signals from moving averages while oscillators remain neutral. The token faces resistance near Rp1,937 with support at Rp1,823. Hold time of 43 days suggests moderate holding patterns. No major protocol updates or ecosystem developments were identified in recent analysis.
Overall outlook remains cautious with bearish technical pressure outweighing neutral momentum indicators. Key opportunity lies in potential bounce from support levels, while major risks include limited liquidity and the prevailing bearish trend. Investors should monitor for any protocol developments that could shift sentiment.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Shentu Chain, a security-first, delegated proof-of-stake blockchain, for trustworthy execution of mission-critical applications, including DeFi, NFTs, and autonomous vehicles. Shentu Chain prioritizes cross-chain compatibility, built as a Cosmos Hub with full EVM and Hyperledger Burrow compatibility, as well as compatibility with eWASM and Ant Financial’s AntChain.
Read more on CTK →